Chancellor Rachel Reeves Aims for Focused Action on Household Expenses in Upcoming Budget
Treasury head Rachel Reeves has announced she is preparing "focused measures to tackle cost of living pressures" in the upcoming financial statement.
During an interview with the BBC, she stated that reducing inflation is a joint task of both the administration and the Bank of England.
The UK's price growth is forecast to be the highest among the Group of Seven developed nations this calendar year and next.
Potential Energy Cost Interventions
Reports indicate the administration could intervene to lower utility costs, for example by slashing the current 5% level of value-added tax applied on energy supplies.
A further approach is to cut some of the policy costs currently added to household expenses.
Budgetary Constraints and Analyst Predictions
The government will receive the next draft from the official forecaster, the OBR, on the start of the week, which will reveal how much room there is for such actions.
The view from most economists is that Reeves will have to declare tax rises or budget cuts in order to fulfill her voluntary debt limits.
Previously on Thursday, estimates showed there was a £22 billion shortfall for the chancellor to resolve, which is at the lower end of projections.
"It is a shared task between the Bank of England and the government to further reduce some of the causes of price increases," Reeves told the BBC in the US capital, at the conferences of the IMF and World Bank.
Tax Pledges and Global Issues
While much of the focus has been on probable tax increases, the Treasury chief said the latest information from the OBR had not changed her vow to manifesto promises not to increase tax levels on earnings tax, sales tax or National Insurance.
She attributed an "uncertain global environment" with rising international and trade issues for the fiscal revenue measures, probably to be targeted on those "wealthiest."
Global Economic Disputes
Referring to apprehensions about the United Kingdom's commercial links with the Asian nation she said: "The UK's national security always come first."
Recent announcement by China to strengthen trade restrictions on critical minerals and other resources that are crucial for advanced tech manufacturing led American leader the US President to threaten an extra 100% import tax on goods from the Asian country, increasing the risk of an full-scale commercial conflict between the two economic giants.
The US Treasury Secretary described the Chinese move "economic coercion" and "a global supply chain power grab."
Inquired about accepting the American proposal to join its conflict with China, Reeves said she was "deeply worried" by Chinese measures and encouraged the Beijing authorities "to avoid restrictions and limit trade."
She said the decision was "damaging for the global economy and creates further obstacles."
"It is my opinion there are areas where we need to challenge China, but there are also significant opportunities to sell into China's economy, including financial services and other sectors of the economic system. We've got to get that balance correct."
The chancellor also stated she was collaborating with G7 counterparts "on our own essential resources approach, so that we are more independent."
Health Service Medicine Pricing and Investment
The Chancellor also admitted that the cost the National Health Service spends on pharmaceuticals could increase as a consequence of ongoing talks with the US government and its pharmaceutical firms, in exchange for lower tariffs and funding.
A number of the world's largest pharmaceutical manufacturers have said in recent statements that they are either delaying or scrapping investments in the United Kingdom, with some attributing the modest returns they are getting.
Last month, the government science advisor said the price the NHS pays for drugs would need to increase to halt firms and pharmaceutical investment leaving the United Kingdom.
The Chancellor informed the BBC: "It has been observed as a result of the cost structure, that clinical trials, innovative medicines have not been available in the United Kingdom in the manner that they are in other EU nations."
"The objective is to ensure that patients getting treatment from the National Health Service are can obtain the top critical treatments in the world. And so we are reviewing this situation, and... seeking to obtain more investment into Britain."